| TM group n = 230 | Control group n = 104 | P |
---|---|---|---|
MRC Dyspnea Score [No of participants (%)] | Â | Â | 0.64 |
 • Level 1 | 26 (11.30%) | 10 (9.62%) |  |
 • Level 2 | 60 (26.09%) | 32 (30.77%) |  |
 • Level 3 | 65 (28.26%) | 25 (24.04%) |  |
 • Level 4 | 53 (23.04%) | 29 (27.88%) |  |
 • Level 5 | 26 (11.30%) | 8 (7.69%) |  |
CAT Score [mean (SD)] | 15.23 (8.21) | 14.00 (6.82) | 0.37 |
HADS Score [mean (SD)] | |||
 • Anxiety | 4.68 (3.45) | 5.4 (3.35) | 0.09 |
 • Depression | 5.1 (4.42) | 5.48 (4.49) | 0.6 |
SF36v2 | Â | Â | Â |
 • PCS | 38.36 (9.79) | 37.33 (9.42) | 0.42 |
 • MCS | 44.78 (11.29) | 44.57 (11.42) | 0.88 |
Cardiovascular comorbidity [No of participants (%)] | Â | Â | 0.63 |
 • Hypertension, n | 94 (61.04%) | 51 (64.56%) |  |
 • Ischemic Heart Disease, n | 60 (38.96%) | 28 (35.44%) |  |
Prescribed medication [No of participants (%)] | |||
 • LABA | 221 (97.79%) | 96 (94.12%) | 0.11 |
 • LAMA | 197 (87.17%) | 88 (86.27%) | 1 |
 • Inhaled steroid | 192 (83.48%) | 80 (76.92%) | 0.18 |
 • Systemic steroid | 15 (6.52%) | 5 (4.81%) | 0.36 |
LTOT [No of participants (%)] | 95 (41.30%) | 41 (39.42%) | 0.76 |
Pulmonary Function Test [mean (SD)] | Â | Â | Â |
 • FEV1, L | 1.06 (0.59) | 1.09 (0.54) | 0.99 |
 • FEV1, % | 41.90 (8.64) | 41.87 (8.30) | 0.56 |
Arterial Blood Gas [mean (SD)] | |||
 • PCO2, mmHg | 44.31 (7.64) | 48.85 (9.28) | <0.004 |
 • PO2, mmHg | 65.65 (9.89) | 65.01 (10.98) | 0.81 |
6-min WT, mt [mean (SD)] | 263.4 (95.9) | 213.1 (109.4) | 0.32 |